ストックスクリーナーアプリを入手
4.85
16.23%
-0.94
アフターアワーズ：
4.02
-0.83
-17.11%
前日終値:
$5.79
開ける：
$4.85
24時間の取引高:
3.21M
Relative Volume:
2.75
時価総額：
$3.44M
収益：
-
当期純損益:
$-12.88M
株価収益率:
-0.1361
EPS:
-35.6417
ネットキャッシュフロー:
$-8.79M
1週間 パフォーマンス:
-33.65%
1か月 パフォーマンス:
+33.61%
6か月 パフォーマンス:
-70.92%
1年 パフォーマンス:
-72.25%
1日の値動き範囲:
$4.24
$5.78
1週間の範囲:
$4.24
$9.80
52週間の値動き範囲:
$3.15
$85.80
Artelo Biosciences Inc Stock (ARTL) Company Profile
名前
Artelo Biosciences Inc
セクター
電話
858-925-7049
住所
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
4.85 | 4.10M | 0 | -12.88M | -8.79M | -35.64 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-08 | アップグレード | D. Boral Capital | Hold → Buy |
| 2021-02-12 | 開始されました | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc (ARTL) 最新ニュース
Algorand Edges Lower: No Catalysts Amid Pharma Noise - Bitget
Artelo Biosciences (ARTL) Explores New Avenues for Muscle Preser - GuruFocus
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments - The Manila Times
GLP-1 weight loss can cut lean mass; Artelo starts protection study - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Artelo Biosciences Expands Clinical Pipeline into Glaucoma Market with Investigator-Sponsored Study - Quiver Quantitative
Artelo Biosciences Expansion into $16.3B Glaucoma Market, - GlobeNewswire
[S-1] ARTELO BIOSCIENCES, INC. F... - Stock Titan
Artelo Biosciences (ARTL) seeks $10.9M in dilutive stock and warrant raise - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Nano-cap Artelo Biosciences stock explodes — glaucoma study collaboration ignites rally - MSN
[S-1/A] ARTELO BIOSCIENCES, INC. Amends IPO Registration Statement - Stock Titan
Why is ARTL stock soaring pre-market today? - MSN
ARTL Stock Price, Quote & Chart | ARTELO BIOSCIENCES INC (NASDAQ:ARTL) - ChartMill
Artelo Biosciences Surges with Groundbreaking Glaucoma Study Announcement - timothysykes.com
Artelo Biosciences (NASDAQ: ARTL) details $10.8M S-1 stock sale - Stock Titan
Artelo Biosciences, Inc.Common Stock (NQ: ARTL - The Chronicle-Journal
Artelo Biosciences Surges on Glaucoma Study Announcement - StocksToTrade
Artelo Biosciences Jumps 28% During the Day Amid Uncertainty Fueling Market Fluctuations and Rumors - Bitget
Artelo Biosciences Surges 28% Intraday as Mystery Drives Volatility and Speculation - Bitget
Artelo Biosciences Expands Market Footprint: Stock Soars Amid Glaucoma Study Initiatives - timothysykes.com
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Small Cap Stocks To Watch Now – March 18th - Defense World
Crude Oil Moves Higher; Jabil Shares Slide After Q2 Results - Sahm
3 Penny Stocks to Watch Now, 3/19/26 - TipRanks
Artelo Biosciences Enters Securities Purchase Agreements for Bridge Notes with Vanquish Funding Group and Boot Capital LLC - Minichart
Artelo Biosciences Secures Bridge Financing Through Note Issuance - TipRanks
Artelo Biosciences Raises $310,000 in 12% Bridge Notes From Vanquish and Boot - TradingView
Artelo Biosciences (NASDAQ: ARTL) raises cash via 12% bridge notes - Stock Titan
Artelo Biosciences, Inc. 2025 Financial Results: Going Concern Risks, Capital Raises, and Significant Losses Detailed in Annual Report - Minichart
Small Cap Stocks To Watch NowMarch 18th - MarketBeat
Why Is Artelo Biosciences Stock Surging Today?Artelo Biosciences (NASDAQ:ARTL) - Benzinga
Artelo Biosciences completes 1-for-3 reverse stock split By Investing.com - Investing.com India
Artelo Biosciences (ARTL) Soars 40% After Securing Fully-Funded Glaucoma Trial Partnership - MEXC
Artelo Biosciences stock surges on glaucoma study agreement By Investing.com - Investing.com South Africa
Artelo Biosciences stock surges on glaucoma study agreement - Investing.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Artelo Biosciences moves into glaucoma research with fully funded clinical study - MSN
Artelo Biosciences (ARTL) Stock Jumps 40% on Surprise Glaucoma Study News - MEXC
Artelo announces third-party fully funded clinical study agreement for ART27.13 - TipRanks
Artelo Biosciences’ Stock Increases with Positive R&D Updates - StocksToTrade
Artelo Biosciences jumps as it expands ART27.13 into glaucoma via fully funded clinical study - Quiver Quantitative
Artelo Biosciences (ARTL) Stock Rockets 40% Following Glaucoma Trial Partnership - parameter.io
Artelo Biosciences Shares Surge Amid Promising Research Updates - timothysykes.com
Dow Falls Over 150 POints; US Producer Prices Increase In February - Benzinga
Morning Market Movers: ARTL, SWMR, OVID, HIT See Big Swings - RTTNews
Artelo Biosciences (ARTL) Explores New Glaucoma Treatment in Upc - GuruFocus
Why Is ARTL Stock Soaring Pre-Market Today? - Asianet Newsable
Artelo Biosciences and Belfast Health and Social Care Trust Enter Definitive Investigator-Initiated Study Agreement - marketscreener.com
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study - marketscreener.com
Clinical Collaboration and Funding Arrangement: Artelo Biosciences, Inc. (NASDAQ: ARTL) announces the signing of a third-party fully funded clinical research agreement to advance the evaluation of its candidate drug ART27.13 in glaucoma patients. - Bitget
Artelo Biosciences Inc (ARTL) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):